In the article titled “Prevalence of Fracture Risk Factors in Postmenopausal Women Enrolled in the POSSIBLE US Treatment Cohort” [1], there was an error regarding the FRAX® tool, which should be clarified as follows:
The article notes “The WHO fracture risk assessment tool (FRAX) is a computer-based algorithm that assesses fracture probability of men and women [1].” However, the World Health Organization (WHO) did not develop, test, or endorse the FRAX tool or its recommendations [2]. The metabolic bone disease unit at the University of Sheffield that developed FRAX was a WHO Collaborating Centre from 1991 to 2010, but treatment guidelines must undergo a formal process before they can be endorsed by the WHO.
References
- 1.Yurgin N., Wade S., Satram-Hoang S., Macarios D., Hochberg M. Prevalence of fracture risk factors in postmenopausal women enrolled in the POSSIBLE US treatment cohort. International Journal of Endocrinology. 2013;2013:9. doi: 10.1155/2013/715025.715025 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Ford N., Norris S. L., Hill S. R. Clarifying WHO’s position on the FRAX® tool for fracture prediction. Bulletin of the World Health Organization. 2016;94(12):p. 862. doi: 10.2471/BLT.16.188532. [DOI] [PMC free article] [PubMed] [Google Scholar]